Mirae Asset Global ETFs Holdings’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,009
Closed -$198K 3093
2025
Q2
$198K Buy
2,009
+19
+1% +$1.8K ﹤0.01% 2290
2025
Q1
$184K Buy
1,990
+176
+10% +$16.2K ﹤0.01% 2367
2024
Q4
$165K Sell
1,814
-37
-2% -$3.4K ﹤0.01% 2478
2024
Q3
$179K Buy
1,851
+22
+1% +$2.15K ﹤0.01% 2417
2024
Q2
$168K Buy
+1,829
New +$170K ﹤0.01% 2342

Other funds holding AMED

Mirae Asset Global ETFs Holdings's AMED Position: Q3 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Amedisys (AMED) in Q3 2025, closing a stake of 2,009 shares — an estimated $198K sold.

Mirae Asset Global ETFs Holdings first reported a position in AMED in Q2 2024 and held it in 5 quarters. The position peaked at $198K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 2,009 Amedisys shares in Q3 2025, an estimated $198K.
  • Mirae Asset Global ETFs Holdings first reported a position in Amedisys in Q2 2024 and held it in 5 quarters.
  • Mirae Asset Global ETFs Holdings's Amedisys position peaked at $198K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.